Loading...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). Repurposed ALS drug shows promise in mouse model of rare childhood genetic disorder 11/19/2021 11:00 AM ESTNPC1 leads to difficulty controlling movements, liver and lung disease, impaired swallowing, intellectual decline and death.
|
Loading...
Loading...